Indian Journal of Urology Users online:3618  
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
Year : 2007  |  Volume : 23  |  Issue : 1  |  Page : 51-54

Use of bisphosphonates in prostate cancer: Current status

Department of Urology, All India Institute of Medical Sciences, New Delhi - 110 029, India

Correspondence Address:
Rishi Nayyar
C-61, New Multan Nagar, Rohtak Road, New Delhi
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0970-1591.30267

Rights and Permissions

Bisphosphonates are a relatively newer class of drugs which have been used for the prevention of skeletal related complications of age related osteoporosis or metastatic disease from carcinoma breast or multiple myeloma. Their role in the management of prostate cancer is still under evolution. We hereby review the ongoing and some published randomized trials to define the role of bisphosphonates in various stages of prostate cancer.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded456    
    Comments [Add]    

Recommend this journal